Next Article in Journal
Imidocarb Dipropionate Lacks Efficacy against Theileria haneyi and Fails to Consistently Clear Theileria equi in Horses Co-Infected with T. haneyi
Next Article in Special Issue
MiR-378b Modulates Chlamydia-Induced Upper Genital Tract Pathology
Previous Article in Journal
Closing the Gaps to Understand the Tick Transmission of Anaplasma marginale among Giant Anteaters (Myrmecophaga tridactyla) in Argentina
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 9
Issue 12
10.3390/pathogens9121034
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hijacking and Use of Host Kinases by Chlamydiae

by
Prakash Sah
and
Erika I. Lutter
*
Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078, USA
*
Author to whom correspondence should be addressed.
Pathogens 2020, 9(12), 1034; https://doi.org/10.3390/pathogens9121034
Submission received: 10 October 2020 / Revised: 1 December 2020 / Accepted: 7 December 2020 / Published: 10 December 2020
(This article belongs to the Special Issue Unraveling Chlamydial Pathogenesis)
Browse Figures
Versions Notes

Abstract

:
Chlamydia species are causative agents of sexually transmitted infections, blinding trachoma, and animal infections with zoonotic potential. Being an obligate intracellular pathogen, Chlamydia relies on the host cell for its survival and development, subverting various host cell processes throughout the infection cycle. A key subset of host proteins utilized by Chlamydia include an assortment of host kinase signaling networks which are vital for many chlamydial processes including entry, nutrient acquisition, and suppression of host cell apoptosis. In this review, we summarize the recent advancements in our understanding of host kinase subversion by Chlamydia.

1. Introduction

Chlamydiae species are obligate intracellular pathogens that represent a significant burden to healthcare and the economy. Human infections are caused by two species: Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. C. trachomatis causes infections of ocular and genital tract epithelium [1]. Ocular infections caused by C. trachomatis are the leading infectious cause of preventable blindness worldwide [2]. Genital tract biovars comprised of serovars D-K are the most frequently reported bacterial sexually transmitted infections (STIs) in the United States [3]. The majority of infections are asymptomatic which facilitate transmission of this pathogen. Chronic infections lead to complications such as pelvic inflammatory disease (PID), ectopic pregnancy, and infertility. Furthermore, C. trachomatis infections can facilitate HIV transmission and have been associated with an increased risk of cervical cancer [4,5]. Lymphogranuloma venereum (LGV) biovars comprised of serovars L1-L3 cause invasive infections of the urogenital tract [5]. C. pneumoniae is a frequent cause of community acquired pneumonia and has been associated with several chronic diseases such as atherosclerosis [6,7]. Non-human infections are caused by various Chlamydiae strains including Chlamydia muridarum, Chlamydia caviae and Chlamydia psittaci. C. muridarum is a mouse adapted strain used as model for studying genital infections while C. caviae and C. psittaci are pathogens of veterinary importance [8,9]. C. psittaci is a known zoonotic agent causing respiratory infections in humans and recently C. caviae is also emerging as a zoonotic agent [10,11,12].
Despite variations in infections caused and hosts targeted, Chlamydia species all share a common infection cycle. Chlamydia have a unique biphasic developmental cycle consisting of alternation between two distinct forms: the infectious elementary bodies (EBs) and the non-infectious reticulate bodies (RBs) [13,14]. Upon contact with the host cell, EBs mediate uptake by the host in a membrane bound compartment called an inclusion and avoids fusion with lysosomes [15]. EBs transition to RBs within the inclusion and undergo several rounds of replication. About mid-way through the life cycle RBs asynchronously start to re-differentiate back into EBs. At the end of the life cycle, about 48–72 h, EBs are released from the host cell via lysis or extrusion to infect neighboring cells [16].
Being obligate intracellular in nature, Chlamydia are reliant on various host cell process for their growth and development. From within the inclusion, Chlamydia usurps various host processes to acquire nutrients, modulate host immune response, maintain inclusion integrity, and prevent apoptosis until exit. Many of these host cell processes are regulated via phosphorylation events by several host kinases. Thus, subversion of the host kinases may be integral to the intracellular life style of Chlamydia. Several studies have highlighted the roles of host kinases in different stages of Chlamydia life cycle to promote growth and development. Within this review, we focus on the various roles that host kinases play in different aspects of chlamydial infections. A summary of host kinases subverted by Chlamydia is shown in Table 1.

2. Host Kinases Important for Chlamydial Entry and Invasion

The very first step in the infection cycle is invasion and entry, a process that utilizes many host kinases. Chlamydia employs several adhesins that bind to receptors on the host cells to promote attachment and entry into the host cell. Among these, several receptor tyrosine kinases (RTKs), including platelet derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), and EphrinA2 receptor (EphA2) are utilized for chlamydial attachment and subsequent host cell entry [18,31,34]. Overall, RTKs play a similar role in chlamydial infection in that they contribute to binding/invasion and activating downstream signaling to regulate other aspects of chlamydial development. Utilizing a large scale high throughput RNA interference screen identified PDGFRβ as important host factor for C. muridarum binding and invasion [18]. PDGFRβ was suggested as a receptor for C. muridarum binding as siRNA mediated depletion of PDGFRβ or treatment with neutralizing antibody against PDGFRβ resulted in a significant decrease in binding to host cell [18]. The same study also found that independent activation of Abl kinase was required for invasion. Activation of PDGFRβ and/or Abl kinase led to phosphorylation of actin modulating proteins Vav2, WAVE2, and cortactin [18]. Given its role in binding and invasion, PDGFRβ has been identified as potential therapeutic target for topical siRNA based therapy. Recently, PDGFRβ knockdown via siRNA-encapsulated nanoparticles has been shown to decrease C. trachomatis infection [59]. C. trachomatis and C. muridarum EBs also bind to fibroblast growth factor 2 (FGF2) enabling their attachment to FGFR leading to localized FGFR activation and entry of EBs into non-phagocytic cells [31]. Further, C. trachomatis and C. muridarum stimulate FGF2 expression via extracellular signal-regulated kinase ½ activation (ERK1/2) and its release from the host cell facilitating subsequent rounds of infection [31]. Inhibition of both FGFR and PDGFR using chemical inhibitors resulted in a significant decrease in internalization of C. muridarum while only a small effect was seen when either FGFR or PDGFR was inhibited indicating these two RTKs may function redundantly in Chlamydial invasion [31]. However, the bacterial factors that mediate FGF2 and PDGFR binding are currently unknown. In C. trachomatis infections, there are distinct functional requirements of EGFR and PDGFR. Specifically, EGFR activation was found to be important for attachment, internalization, inclusion development, and F-actin assembly around the inclusion while PDGFR was only required during initial chlamydial attachment [18,33]. An RNA interference screen identified EphA2 as another receptor for C. trachomatis entry which was confirmed via adherence assay [34]. EphA2 was shown to be a chlamydial adherence and invasion protein required for C. trachomatis development and inhibiting apoptosis by activating the Phosphatidylinositol-3 kinase (PI3K) pathway [34]. Multiple studies have shown that inactivation of PI3K, Rac or Cdc42 inhibit host cell invasion, however, the mechanism of PI3K activation is yet to be deciphered [60,61,62]. During replication, activated EphA2 accumulates around the inclusion interacting with PI3K (at the p85 regulatory subunit) thereby contributing to the activation of the PI3K/Akt signaling pathway which is subsequently essential for normal chlamydial development [34]. Akt phosphorylation at Ser 473 occurs in a binomial manner, early in infection and again around 12 h post-infection [38].
Focal adhesion kinase (FAK) recruitment is important for C. caviae invasion as invasion efficiency of C. caviae is markedly reduced in FAK- and vinculin-knockout cells [24,63]. FAK recruitment is mediated by the translocated actin recruitment protein (TarP) [24]. TarP contains a leucine-aspartate (LD) motif in the F-actin binding domain (FAB1) that binds FAK and mediates actin assembly in a Cdc42 and Arp2/3 dependent manner [24,64]. Unlike TarP from other chlamydial species, the C. pneumonaie ortholog lacks the binding domain for FAK [24,64]. However, C. pneumoniae can alternatively activate FAK signaling in addition to MAP kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) and PI3K for entry and invasion [23]. A subsequent study showed that C. pneumoniae polymorphic membrane protein 21 (pmp21) binds to epidermal growth factor receptor (EGFR). siRNA depletion of EGFR significantly reduced C. pneumoniae adhesion and internalization while ectopic expression of EGFR in receptor-negative cells resulted in increased adhesion and internalization [32]. C. pneumoniae EBs binding to the EGFR receptor activated the MAP kinase pathway resulting in rapid activation and phosphorylation of ERK1/2[32]. Overall, chlamydial host cell entry is a complex process that is highly reliant on host kinases and signaling networks for remodeling cytoskeletal actin.

3. Host Kinases in Nutrient Acquisition by Chlamydia

Chlamydia have a reduced genome, lacking genes for proteins in several metabolic pathways and thus are dependent on the host for its many metabolic requirements [65]. Host derived lipids are important for bacterial replication, inclusion development, homotypic fusion of inclusions, conversion of RBs to EBs, and reactivation from persistence [47,66,67]. Host glycerolipids are acquired and modified by C. trachomatis, a process that requires cytosolic phospholipase A2 activation via the MAP kinase pathway (Ras/Raf/MEK/ERK) [48,68].
Rottlerin, an inhibitor of several host serine/threonine kinases including protein kinase C δ (PKCδ) was shown to affect C. trachomatis development and block sphingolipid acquisition [46]. A previous study had shown PKCδ to be in proximity of the inclusion [45]. Based on this, it was suggested that PKCδ may play a role in lipid acquisition. However, since then rottlerin has been discredited as specific inhibitor of PKCδ [69] and hence the role of PKCδ in lipid acquisition needs further investigation. Most recently, multiple PKC isoforms were found to be localized to inclusion microdomains in C. trachomatis [44]. Additional roles for PKC are discussed later regarding inhibition of apoptosis.
Phosphatidylinositol 4-kinase II-alpha (PI4KIIα), a host kinase that generates Phosphatidylinositol-4-phoshate (PI4P), is recruited to the inclusion. While PIP4 is important for infectivity as seen by siRNA depletion [35], it is not necessary for CERT recruitment to the inclusion [70,71], thereby leaving its role at the inclusion undefined. It has, however, been suggested that the abundance of PI4P at the inclusion may recruit PI4P binding proteins that regulate lipid trafficking, but this has yet to be determined [47].
A study using siRNA depletion screens identified Fyn, a Src family kinase (SFK) member that also localizes at microdomains, to be important for sphingolipid acquisition by C. trachomatis [26]. SFKs at microdomains regulate inclusion trafficking along microtubules to the microtubule organization center (MTOC) and hence may hijack the vesicular transport along microtubules. A recent study found C. trachomatis utilizes the Akt/AS160 signaling pathway to acquire sphingolipids via Rab14 mediated vesicular transport [41]. Akt remains phosphorylated and recruited to the inclusion membrane for the duration of infection and is essential for chlamydial replication, inclusion size, and infectivity [41].

4. Src Family Kinase Rich Microdomains

Active SFKs, non-receptor membrane associated tyrosine kinases, co-localize with at least nine inclusion membrane proteins (Incs) including IncB, IncC, CT101/Myosin Regulatory Complex subunit A (MrcA), CT222, CT223, CT224, CT228, CT288, and CT850 at discrete cholesterol rich sites called microdomains on C. trachomatis inclusions [27,28,72]. Interestingly, SFK recruitment, specifically Src and Fyn, is only observed in human Chlamydia infecting species (C. trachomatis and C. pneumoniae) [27]. These microdomains on the chlamydial inclusion have been shown to be a platform for regulating various processes important for C. trachomatis development. Inhibition of Src kinase or growth in a Src deficient cell line resulted in significant reduction in association of C. trachomatis inclusions with the MTOC as well as reduced infectious progeny production [25]. Thus, SFKs regulate microtubule dependent trafficking of the nascent inclusion to the MTOC and intracellular development [25]. C. caviae and C. muridarum do not recruit SFKs and do not traffic to the MTOC [27]. In addition, chemical inhibition of Src or growth in a Src deficient cell line led to an increase in infectious progeny production suggesting that Src may play a role in restricting growth of these Chlamydia species [25].
CT228 and CT101/MrcA have been shown to regulate extrusion via the myosin phosphatase pathway (Figure 1) [28,29,30]. CT228 binds to and recruits MYPT1 to the chlamydial inclusion [28,30]. MYPT1 phosphorylated at residues T853 and T696 colocalizes with active SFK laden microdomains along with other proteins of myosin pathway, Myosin light chain 2 (MLC2), Myosin light chain kinase (MLCK), and the heavy chains, Myosin IIA and B [28]. siRNA mediated depletion of MLCK, MLC2, Myosin IIA and B resulted in decreased extrusion production by C. trachomatis [28]. MrcA binds to the inositol 1,4,5-triphosphate receptor 3 (ITPR3) which works with stromal interaction molecule 1 (STIM1) to regulate Ca2+ release, ensuring MLCK is active and phosphorylates MLC2 to regulate extrusion [28,29]. Overall, a complex interplay between MLCK and a phosphatase at the SFK microdomains regulates chlamydial exit strategies and determines whether C. trachomatis exits the host via lysis or extrusion.

5. Phosphorylation of Chlamydia Effectors by Host Kinases

C. trachomatis encodes a T3SS to secrete effector proteins that localize into the host cytosol or inclusion membrane [65,73]. The well-known TSSS effector, TarP, is required for actin recruitment during Chlamydia entry into the host cell [17]. TarP modulates actin via activity of different domains that resemble mammalian signaling motifs, recruiting actin and Arp2/3 complex [74]. The tyrosine-phosphodomain in the N-terminal of TarP is only found in C. trachomatis serovars and is phosphorylated by host kinases (Src, Abl, Syk) leading to recruitment of the Arp2/3 complex [17,18,19,20,39,60,75]. TarP phosphorylation is not necessary for F-actin assembly as TarP can activate FAK directly by mimicking the FAK cofactor paxillin [24,64]. This is due to the C-terminal being highly conserved among Chlamydia, which contains an LD motif that binds to FAK leading to recruitment of Arp2/3, except in C. pneumoniae which lacks a LD motif [24,64].
Translocated early phospho-protein (TepP) is another T3SS secreted effector that is tyrosine phosphorylated by the host kinase Src at multiple tyrosine residues after delivery into the host cell [21,22]. TepP recruits Crk adaptor proteins, GSK3β, and PI3K to the early inclusion, independent of Src phosphorylation and plays a role in regulating the innate immune response to Chlamydia [21]. Activated PI3K signaling leads to phosphorylation of phosphoinositide (4,5)-bisphosphate (PIP2) to generate phosphoinositide (3,4,5)-triphosphate (PIP3) which is localized on early inclusions [21]. Interestingly, PI3K activation is spatially limited to the inclusion and does not include the PI3K at the plasma membrane, and as such Akt is not activated [21]. Overall, these studies demonstrate that TepP can modulate PI3K and may have a role in membrane trafficking.
Incs are chlamydial effectors that are translocated across and inserted into the inclusion membrane facing the host cytosol [76,77,78,79]. IncA was the first Inc effector to be discovered in C. psittaci and was reported to be phosphorylated by host kinases [80,81]. C. trachomatis IncG was subsequently shown to be phosphorylated in the host cell as well [82]. While the role of IncA/IncG phosphorylation in chlamydial biology/pathogenesis is unknown, recent studies have indicated the possibility of more Incs being phosphorylated by host kinases. A large-scale Human–Inc interactome study found Incs binding to host kinases while proteome analysis of isolated mid-cycle C. trachomatis inclusions also showed association of various host kinases with the inclusion [83,84]. More recently, phosphoproteomic analysis of C. trachomatis infected cells revealed several chlamydial proteins, including several Incs, to be phosphorylated. Predicted host kinases that could phosphorylate chlamydial proteins included protein kinase A (PKA), PKC, casein kinase 2 (CK2), and GSK3β among other host kinases [54]. Interestingly, PKC and GSK3β have been shown to localize at the inclusion during infection [44,45]. Studying the role of Inc phosphorylation awaits future investigations. Such studies would require mutation analysis of phosphorylation sites on Incs. Recent advancements in chlamydial mutagenesis and availability of shuttle vectors with different selection markers will aid in these investigations. However, challenges such as low transformation efficiency and the time-consuming, laborious nature of chlamydial mutagenesis remain.

6. Apoptosis Resistance

As an intracellular pathogen, it is important for Chlamydia to keep the host cell alive for optimal growth. Chlamydia promote host cell survival via activating pro-survival signaling, downregulating pro-apoptotic proteins, upregulating or stabilizing pro-survival proteins, and sequestering pro-apoptotic proteins to the inclusion (Figure 2) [85,86]. MEK/ERK signaling and PI3K pathways modulate apoptosis and survival and are activated during entry of C. trachomatis, C. muridarum and C. pneumoniae by their binding to host RTKs (discussed above) [18,31,32,34]. Phosphorylated TarP interacts with SRC homology 2 domain-containing transforming protein C1 (SHC1) during entry to promote host cell survival during C. trachomatis infection by activating MEK/ERK signaling [87]. It was observed that apoptosis resistance in C. trachomatis infected cells was mediated by ERK signaling and up regulation of the anti-apoptotic BCL-2 family member MCL-1 (followed by PI3K-dependent stabilization) and BAG family molecular chaperone regulator 1 (BAG1) [36,53,58]. During C. trachomatis infection, the PI3K pathway activates Akt. This PI3K/Akt activation contributes to maintaining pro-apoptotic BAD in a phosphorylated state which is sequestered by 14-3-3β at the inclusion [38]. 14-3-3β is released if PI3K is inhibited by LY294002 while depletion of AKT through short-interfering RNA reverses apoptosis resistance in C. trachomatis infected cells [38]. Downstream of PI3K signaling, 3-phosphoinositide-dependent protein kinase 1 (PDPK1) promotes apoptosis resistance in C. trachomatis infected cells by stabilizing MYC through phosphorylation at Ser 62. MYC stabilization leads to upregulation of hexokinase II (HKII) and enrichment of HKII at the mitochondria inhibiting cell apoptosis [42].
PKCδ sequestration to the C. trachomatis inclusion has been implicated to contribute to apoptosis resistance [45]. Recruiting PKCδ to the inclusion causes redistribution of this pro-apoptotic kinase away from the mitochondria and nuclease resulting in anti-apoptotic effects. Using co-immunoprecipitation and GST pull-down assays, C. pneumoniae Inc Cpn1027 has been shown to interact with members of the WNT-pathway, cytoplasmic activation/proliferation-associated protein-2 (CAPRIN2) and GSK3β. This interaction may contribute to apoptosis resistance by activating the transcription of pro-survival genes [43]. Interestingly, inhibition of WNT signaling via small molecule inhibitor, IWP2, has also been shown to impair C. trachomatis infection [88]. The T3SS effector TepP recruits GSK3β to the early C. trachomatis inclusion [21], however whether this interaction modulates WNT signaling remains unknown. Overall, interaction with these signaling pathways ensures that Chlamydia’s requirements are met without triggering host apoptosis.

7. Immunopathology of Chlamydial Infections and Association with Chronic Diseases

Chronic infection with Chlamydia has been epidemiologically linked with development of inflammatory diseases. C. trachomatis infection can lead to sequelae such as PID, infertility, and has been associated with development of cervical cancer [4,5]. Recognition of Chlamydia by the host cell results in an inflammatory response which is required for bacterial clearance but is also responsible for the immunopathology of chlamydial infections [85,86,89]. C. trachomatis induces proinflammatory interleukin-8 (IL-8) during infection via activation of ERK and p38 kinase signaling [49,50]. Contrary to this, ERK and p38 were also shown to upregulate production of the anti-inflammatory cytokine IL-10, which in turn downregulates production of pro-inflammatory cytokines via JAK/STAT3 signaling [52]. It has been suggested that ERK and p38 signaling may play a role maintaining a balance between pro- and anti-inflammatory response. Additionally, TepP recruits PI3K at the early inclusion to dampen the transcription of type 1 interferon induced genes [21]. The events downstream of PI3K activation which lead to the altered immune response are not yet known.
C. trachomatis promotes host DNA damage by eliciting reactive oxygen species production while impairing the DNA damage responses (DDR). Even with impaired DDR, C. trachomatis keeps its host proliferating via ERK signaling (among other signaling pathways) creating an environment that may predispose the host cell to malignant transformation [51]. C. trachomatis has also been shown to reduce the levels of tumor suppressor protein p53 via PI3K/AKT signaling activation during infection to overcome DNA-damage-driven cytotoxic response [37]. C. trachomatis induced epithelial-mesenchymal transition (EMT) has been implicated in molecular pathogenesis of sequelae associated C. trachomatis infections and its role as a risk factor in the development of cervical cancer [90]. A combined phosphoproteome and transcriptome analysis of C. trachomatis infected cells demonstrated that C. trachomatis induced EMT was found to be mediated by ERK dependent phosphorylation of ETS2 repressor factor (ERF) and proto-oncogenic transcription factor ETS1 [54]. Inhibition of ERK activity via U0126 abrogated phosphorylation of these transcription factors and expression of their target genes in C. trachomatis infected cells. Thus, ERK signaling is important for regulation of transcription factors that control EMT.
C. pneumoniae has been associated with atherosclerosis and found in atherosclerotic lesions suggesting a causal role in atherogenesis [6,7]. Early studies implicated C. pneumonaie-induced signal transduction pathways in multiple cell types relevant to atherogenesis. Endothelial cells infected with C. pneumonaie exhibited increased phosphorylation of p44/p42 MAPK and increased activation/translocation nuclear factor–κB (NF-κB) [91]. Heat shock protein 60 (HSP60) also activated macrophages, endothelial cells, and smooth muscle cells resulting in induced expression of adhesion molecules and activation of NF-κB in addition to the production of proinflammatory cytokines [92,93]. Supporting evidence for these initial observations include studies that implicate C. pneumoniae in vascular smooth muscle cell (VSMC) proliferation. VSMC proliferation is responsible for intimal hyperplasia in early atherscelotic lesions. Specifically, C. pneumoniae and its HSP60 induces the proliferation of human VSMCs via Toll like receptor (TLR)4-mediated activation of p44/p42 (ERK1/2) kinase signaling [57]. The role of p44/p42 kinase signaling was also reported in C. pneumoniae induced proliferation of coronary artery smooth muscle cells [56]. Additionally, C. pneumoniae HSP60 induces the inflammatory response via activation of MAPK kinase 3 (MKK3)/p38 signaling enhancing lung inflammation [55]. Furthermore, MKK3 induces NF-κB activation by stimulating the nuclear kinase, mitogen- and stress-activated protein kinase (MSK) 1 initiating the inflammatory response [55].

8. Conclusions

Host kinases regulate host cell processes by phosphorylation of their target proteins. From entry and intracellular development to exit from the host cell, Chlamydia subverts many host kinase signaling pathways to ensure its survival. MEK/ERK and PI3K signaling pathways are among the most prominent kinase signaling networks utilized by Chlamydia in regulating entry, host cell apoptosis resistance, immune response, and even pathology associated with chlamydial infections. Several chlamydial effectors likely interact with but may also phosphorylated by host kinases during infection suggesting their activity may dependent on host signaling pathways. Elucidating the role of chlamydial effector phosphorylation is an intriguing topic for future studies.

Author Contributions

Conceptualization, P.S.; writing original draft, P.S.; revisions, P.S. and E.I.L. reviewing and editing, P.S. and E.I.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by NIH grant 1 R15 AI149439-01.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Belland, R.; Ojcius, D.M.; Byrne, G.I. Chlamydia. Nat. Rev. Microbiol. 2004, 2, 530–531. [Google Scholar] [CrossRef] [PubMed]
  2. Resnikoff, S.; Pascolini, D.; Etya’ale, D.; Kocur, I.; Pararajasegaram, R.; Pokharel, G.P.; Mariotti, S.P. Global data on visual impairment in the year 2002. Bull. World Health Organ. 2004, 82, 844–851. [Google Scholar] [PubMed]
  3. CDC. Sexually Transmitted Disease Surveillance 2018; Department of Health and Human Services: Atlanta, GA, USA, 2019.
  4. Zhu, H.; Shen, Z.; Luo, H.; Zhang, W.; Zhu, X. Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis. Medicine (Baltimore) 2016, 95, e3077. [Google Scholar] [CrossRef]
  5. Malhotra, M.; Sood, S.; Mukherjee, A.; Muralidhar, S.; Bala, M. Genital Chlamydia trachomatis: An update. Indian J. Med. Res. 2013, 138, 303–316. [Google Scholar] [PubMed]
  6. Ngeh, J.; Anand, V.; Gupta, S. Chlamydia pneumoniae and atherosclerosis—What we know and what we don’t. Clin. Microbiol. Infect. 2002, 8, 2–13. [Google Scholar] [CrossRef] [Green Version]
  7. Campbell, L.A.; Kuo, C.C. Chlamydia pneumoniae—An infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2004, 2, 23–32. [Google Scholar] [CrossRef]
  8. Longbottom, D.; Coulter, L.J. Animal chlamydioses and zoonotic implications. J. Comp. Pathol. 2003, 128, 217–244. [Google Scholar] [CrossRef]
  9. Barron, A.L.; White, H.J.; Rank, R.G.; Soloff, B.L.; Moses, E.B. A new animal model for the study of Chlamydia trachomatis genital infections: Infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 1981, 143, 63–66. [Google Scholar] [CrossRef]
  10. Knittler, M.R.; Sachse, K. Chlamydia psittaci: Update on an underestimated zoonotic agent. Pathog. Dis. 2015, 73, 1–15. [Google Scholar] [CrossRef] [Green Version]
  11. Ramakers, B.P.; Heijne, M.; Lie, N.; Le, T.N.; van Vliet, M.; Claessen, V.P.J.; Tolsma, P.J.P.; De Rosa, M.; Roest, H.I.J.; Vanrompay, D.; et al. Zoonotic Chlamydia caviae Presenting as Community-Acquired Pneumonia. N. Engl. J. Med. 2017, 377, 992–994. [Google Scholar] [CrossRef] [Green Version]
  12. van Grootveld, R.; Bilsen, M.P.; Boelsums, T.L.; Heddema, E.R.; Groeneveld, G.H.; Gooskens, J.; de Boer, M.G.J. Chlamydia caviae Causing Community-Acquired Pneumonia: An Emerging Zoonosis. Vector Borne Zoonotic Dis. 2018, 18, 635–637. [Google Scholar] [CrossRef] [PubMed]
  13. Abdelrahman, Y.M.; Belland, R.J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 2005, 29, 949–959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Moulder, J.W. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 1991, 55, 143–190. [Google Scholar] [CrossRef] [PubMed]
  15. Fields, K.A.; Hackstadt, T. The chlamydial inclusion: Escape from the endocytic pathway. Annu. Rev. Cell Dev. Biol. 2002, 18, 221–245. [Google Scholar] [CrossRef] [PubMed]
  16. Hybiske, K.; Stephens, R.S. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc. Natl. Acad. Sci. USA 2007, 104, 11430–11435. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Clifton, D.R.; Fields, K.A.; Grieshaber, S.S.; Dooley, C.A.; Fischer, E.R.; Mead, D.J.; Carabeo, R.A.; Hackstadt, T. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. USA 2004, 101, 10166–10171. [Google Scholar] [CrossRef] [Green Version]
  18. Elwell, C.A.; Ceesay, A.; Kim, J.H.; Kalman, D.; Engel, J.N. RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog. 2008, 4, e1000021. [Google Scholar] [CrossRef] [Green Version]
  19. Mehlitz, A.; Banhart, S.; Hess, S.; Selbach, M.; Meyer, T.F. Complex kinase requirements for Chlamydia trachomatis Tarp phosphorylation. FEMS Microbiol. Lett. 2008, 289, 233–240. [Google Scholar] [CrossRef] [Green Version]
  20. Jewett, T.J.; Dooley, C.A.; Mead, D.J.; Hackstadt, T. Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases. Biochem. Biophys. Res. Commun. 2008, 371, 339–344. [Google Scholar] [CrossRef] [Green Version]
  21. Carpenter, V.; Chen, Y.S.; Dolat, L.; Valdivia, R.H. The Effector TepP Mediates Recruitment and Activation of Phosphoinositide 3-Kinase on Early Chlamydia trachomatis Vacuoles. mSphere 2017, 2. [Google Scholar] [CrossRef] [Green Version]
  22. Chen, Y.S.; Bastidas, R.J.; Saka, H.A.; Carpenter, V.K.; Richards, K.L.; Plano, G.V.; Valdivia, R.H. The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling. PLoS Pathog. 2014, 10, e1003954. [Google Scholar] [CrossRef] [PubMed]
  23. Coombes, B.K.; Mahony, J.B. Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell. Microbiol. 2002, 4, 447–460. [Google Scholar] [CrossRef] [PubMed]
  24. Thwaites, T.; Nogueira, A.T.; Campeotto, I.; Silva, A.P.; Grieshaber, S.S.; Carabeo, R.A. The Chlamydia effector TarP mimics the mammalian leucine-aspartic acid motif of paxillin to subvert the focal adhesion kinase during invasion. J. Biol. Chem. 2014, 289, 30426–30442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Mital, J.; Hackstadt, T. Diverse requirements for SRC-family tyrosine kinases distinguish chlamydial species. mBio 2011, 2. [Google Scholar] [CrossRef] [Green Version]
  26. Mital, J.; Hackstadt, T. Role for the SRC family kinase Fyn in sphingolipid acquisition by chlamydiae. Infect. Immun. 2011, 79, 4559–4568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mital, J.; Miller, N.J.; Fischer, E.R.; Hackstadt, T. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell. Microbiol. 2010, 12, 1235–1249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Lutter, E.I.; Barger, A.C.; Nair, V.; Hackstadt, T. Chlamydia trachomatis inclusion membrane protein CT228 recruits elements of the myosin phosphatase pathway to regulate release mechanisms. Cell Rep. 2013, 3, 1921–1931. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Nguyen, P.H.; Lutter, E.I.; Hackstadt, T. Chlamydia trachomatis inclusion membrane protein MrcA interacts with the inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) to regulate extrusion formation. PLoS Pathog. 2018, 14, e1006911. [Google Scholar] [CrossRef]
  30. Shaw, J.H.; Key, C.E.; Snider, T.A.; Sah, P.; Shaw, E.I.; Fisher, D.J.; Lutter, E.I. Genetic Inactivation of Chlamydia trachomatis Inclusion Membrane Protein CT228 Alters MYPT1 Recruitment, Extrusion Production, and Longevity of Infection. Front. Cell. Infect. Microbiol. 2018, 8, 415. [Google Scholar] [CrossRef] [Green Version]
  31. Kim, J.H.; Jiang, S.; Elwell, C.A.; Engel, J.N. Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection. PLoS Pathog. 2011, 7, e1002285. [Google Scholar] [CrossRef] [Green Version]
  32. Molleken, K.; Becker, E.; Hegemann, J.H. The Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entry. PLoS Pathog. 2013, 9, e1003325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Patel, A.L.; Chen, X.; Wood, S.T.; Stuart, E.S.; Arcaro, K.F.; Molina, D.P.; Petrovic, S.; Furdui, C.M.; Tsang, A.W. Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development. BMC Microbiol. 2014, 14, 277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Subbarayal, P.; Karunakaran, K.; Winkler, A.C.; Rother, M.; Gonzalez, E.; Meyer, T.F.; Rudel, T. EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis. PLoS Pathog. 2015, 11, e1004846. [Google Scholar] [CrossRef] [PubMed]
  35. Moorhead, A.M.; Jung, J.Y.; Smirnov, A.; Kaufer, S.; Scidmore, M.A. Multiple host proteins that function in phosphatidylinositol-4-phosphate metabolism are recruited to the chlamydial inclusion. Infect. Immun. 2010, 78, 1990–2007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Rajalingam, K.; Sharma, M.; Lohmann, C.; Oswald, M.; Thieck, O.; Froelich, C.J.; Rudel, T. Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells. PLoS ONE 2008, 3, e3102. [Google Scholar] [CrossRef] [PubMed]
  37. Siegl, C.; Prusty, B.K.; Karunakaran, K.; Wischhusen, J.; Rudel, T. Tumor suppressor p53 alters host cell metabolism to limit Chlamydia trachomatis infection. Cell Rep. 2014, 9, 918–929. [Google Scholar] [CrossRef] [Green Version]
  38. Verbeke, P.; Welter-Stahl, L.; Ying, S.; Hansen, J.; Hacker, G.; Darville, T.; Ojcius, D.M. Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathog. 2006, 2, e45. [Google Scholar] [CrossRef]
  39. Lane, B.J.; Mutchler, C.; Al Khodor, S.; Grieshaber, S.S.; Carabeo, R.A. Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. PLoS Pathog. 2008, 4, e1000014. [Google Scholar] [CrossRef] [Green Version]
  40. Gurumurthy, R.K.; Maurer, A.P.; Machuy, N.; Hess, S.; Pleissner, K.P.; Schuchhardt, J.; Rudel, T.; Meyer, T.F. A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci. Signal. 2010, 3, ra21. [Google Scholar] [CrossRef]
  41. Capmany, A.; Gambarte Tudela, J.; Alonso Bivou, M.; Damiani, M.T. Akt/AS160 Signaling Pathway Inhibition Impairs Infection by Decreasing Rab14-Controlled Sphingolipids Delivery to Chlamydial Inclusions. Front. Microbiol. 2019, 10, 666. [Google Scholar] [CrossRef]
  42. Al-Zeer, M.A.; Xavier, A.; Abu Lubad, M.; Sigulla, J.; Kessler, M.; Hurwitz, R.; Meyer, T.F. Chlamydia trachomatis Prevents Apoptosis Via Activation of PDPK1-MYC and Enhanced Mitochondrial Binding of Hexokinase II. EBioMedicine 2017, 23, 100–110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Flores, R.; Zhong, G. The Chlamydia pneumoniae Inclusion Membrane Protein Cpn1027 Interacts with Host Cell Wnt Signaling Pathway Regulator Cytoplasmic Activation/Proliferation-Associated Protein 2 (Caprin2). PLoS ONE 2015, 10, e0127909. [Google Scholar] [CrossRef] [PubMed]
  44. Sah, P.; Nelson, N.H.; Shaw, J.H.; Lutter, E.I. Chlamydia trachomatis recruits protein kinase C during infection. Pathog. Dis. 2019, 77, ftz061. [Google Scholar] [CrossRef]
  45. Tse, S.M.; Mason, D.; Botelho, R.J.; Chiu, B.; Reyland, M.; Hanada, K.; Inman, R.D.; Grinstein, S. Accumulation of diacylglycerol in the Chlamydia inclusion vacuole: Possible role in the inhibition of host cell apoptosis. J. Biol. Chem. 2005, 280, 25210–25215. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Shivshankar, P.; Lei, L.; Wang, J.; Zhong, G. Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells. Appl. Environ. Microbiol. 2008, 74, 1243–1249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Elwell, C.A.; Engel, J.N. Lipid acquisition by intracellular Chlamydiae. Cell. Microbiol. 2012, 14, 1010–1018. [Google Scholar] [CrossRef] [Green Version]
  48. Su, H.; McClarty, G.; Dong, F.; Hatch, G.M.; Pan, Z.K.; Zhong, G. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 2004, 279, 9409–9416. [Google Scholar] [CrossRef] [Green Version]
  49. Buchholz, K.R.; Stephens, R.S. The extracellular signal-regulated kinase/mitogen-activated protein kinase pathway induces the inflammatory factor interleukin-8 following Chlamydia trachomatis infection. Infect. Immun. 2007, 75, 5924–5929. [Google Scholar] [CrossRef] [Green Version]
  50. Chen, F.; Cheng, W.; Zhang, S.; Zhong, G.; Yu, P. Induction of IL-8 by Chlamydia trachomatis through MAPK pathway rather than NF-kappaB pathway. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010, 35, 307–313. [Google Scholar]
  51. Chumduri, C.; Gurumurthy, R.K.; Zadora, P.K.; Mi, Y.; Meyer, T.F. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe 2013, 13, 746–758. [Google Scholar] [CrossRef] [Green Version]
  52. Du, K.; Zhou, M.; Li, Q.; Liu, X.Z. Chlamydia trachomatis inhibits the production of pro-inflammatory cytokines in human PBMCs through induction of IL-10. J. Med. Microbiol. 2018, 67, 240–248. [Google Scholar] [CrossRef] [PubMed]
  53. Kun, D.; Xiang-Lin, C.; Ming, Z.; Qi, L. Chlamydia inhibit host cell apoptosis by inducing Bag-1 via the MAPK/ERK survival pathway. Apoptosis 2013, 18, 1083–1092. [Google Scholar] [CrossRef] [PubMed]
  54. Zadora, P.K.; Chumduri, C.; Imami, K.; Berger, H.; Mi, Y.; Selbach, M.; Meyer, T.F.; Gurumurthy, R.K. Integrated Phosphoproteome and Transcriptome Analysis Reveals Chlamydia-Induced Epithelial-to-Mesenchymal Transition in Host Cells. Cell Rep. 2019, 26, 1286–1302.e8. [Google Scholar] [CrossRef] [PubMed]
  55. Kang, Y.; Wang, F.; Lu, Z.; Ying, H.; Zhang, H.; Ding, W.; Wang, C.; Shi, L. MAPK kinase 3 potentiates Chlamydia HSP60-induced inflammatory response through distinct activation of NF-kappaB. J. Immunol. 2013, 191, 386–394. [Google Scholar] [CrossRef] [Green Version]
  56. Rupp, J.; Hellwig-Burgel, T.; Wobbe, V.; Seitzer, U.; Brandt, E.; Maass, M. Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2005, 102, 3447–3452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Sasu, S.; LaVerda, D.; Qureshi, N.; Golenbock, D.T.; Beasley, D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 2001, 89, 244–250. [Google Scholar] [CrossRef] [Green Version]
  58. Du, K.; Zheng, Q.; Zhou, M.; Zhu, L.; Ai, B.; Zhou, L. Chlamydial antiapoptotic activity involves activation of the Raf/MEK/ERK survival pathway. Curr. Microbiol. 2011, 63, 341–346. [Google Scholar] [CrossRef]
  59. Yang, S.; Traore, Y.; Jimenez, C.; Ho, E.A. Autophagy induction and PDGFR-beta knockdown by siRNA-encapsulated nanoparticles reduce chlamydia trachomatis infection. Sci. Rep. 2019, 9, 1306. [Google Scholar] [CrossRef] [Green Version]
  60. Carabeo, R.A.; Dooley, C.A.; Grieshaber, S.S.; Hackstadt, T. Rac interacts with Abi-1 and WAVE2 to promote an Arp2/3-dependent actin recruitment during chlamydial invasion. Cell. Microbiol. 2007, 9, 2278–2288. [Google Scholar] [CrossRef]
  61. Carabeo, R.A.; Grieshaber, S.S.; Hasenkrug, A.; Dooley, C.; Hackstadt, T. Requirement for the Rac GTPase in Chlamydia trachomatis invasion of non-phagocytic cells. Traffic 2004, 5, 418–425. [Google Scholar] [CrossRef]
  62. Subtil, A.; Wyplosz, B.; Balana, M.E.; Dautry-Varsat, A. Analysis of Chlamydia caviae entry sites and involvement of Cdc42 and Rac activity. J. Cell Sci. 2004, 17 Pt 117, 3923–3933. [Google Scholar] [CrossRef] [Green Version]
  63. Thwaites, T.R.; Pedrosa, A.T.; Peacock, T.P.; Carabeo, R.A. Vinculin Interacts with the Chlamydia Effector TarP Via a Tripartite Vinculin Binding Domain to Mediate Actin Recruitment and Assembly at the Plasma Membrane. Front. Cell. Infect. Microbiol. 2015, 5, 88. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Clifton, D.R.; Dooley, C.A.; Grieshaber, S.S.; Carabeo, R.A.; Fields, K.A.; Hackstadt, T. Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect. Immun. 2005, 73, 3860–3868. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Stephens, R.S.; Kalman, S.; Lammel, C.; Fan, J.; Marathe, R.; Aravind, L.; Mitchell, W.; Olinger, L.; Tatusov, R.L.; Zhao, Q.; et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998, 282, 754–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Robertson, D.K.; Gu, L.; Rowe, R.K.; Beatty, W.L. Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog. 2009, 5, e1000664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Van Ooij, C.; Kalman, L.; Van Ijzendoorn, S.; Nishijima, M.; Hanada, K.; Mostov, K.; Engel, J.N. Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell. Microbiol. 2000, 2, 627–637. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Wylie, J.L.; Hatch, G.M.; McClarty, G. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J. Bacteriol. 1997, 179, 7233–7242. [Google Scholar] [CrossRef] [Green Version]
  69. Wu-Zhang, A.X.; Newton, A.C. Protein kinase C pharmacology: Refining the toolbox. Biochem. J. 2013, 452, 195–209. [Google Scholar] [CrossRef] [Green Version]
  70. Derre, I.; Swiss, R.; Agaisse, H. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog. 2011, 7, e1002092. [Google Scholar] [CrossRef]
  71. Elwell, C.A.; Jiang, S.; Kim, J.H.; Lee, A.; Wittmann, T.; Hanada, K.; Melancon, P.; Engel, J.N. Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development. PLoS Pathog. 2011, 7, e1002198. [Google Scholar] [CrossRef] [Green Version]
  72. Weber, M.M.; Bauler, L.D.; Lam, J.; Hackstadt, T. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis. Infect. Immun. 2015, 83, 4710–4718. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Betts-Hampikian, H.J.; Fields, K.A. The Chlamydial Type III Secretion Mechanism: Revealing Cracks in a Tough Nut. Front. Microbiol. 2010, 1, 114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Caven, L.; Carabeo, R.A. Pathogenic Puppetry: Manipulation of the Host Actin Cytoskeleton by Chlamydia trachomatis. Int. J. Mol. Sci. 2019, 21, 90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Lutter, E.I.; Bonner, C.; Holland, M.J.; Suchland, R.J.; Stamm, W.E.; Jewett, T.J.; McClarty, G.; Hackstadt, T. Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype. Infect. Immun. 2010, 78, 3678–3688. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Dehoux, P.; Flores, R.; Dauga, C.; Zhong, G.; Subtil, A. Multi-genome identification and characterization of chlamydiae-specific type III secretion substrates: The Inc proteins. BMC Genom. 2011, 12, 109. [Google Scholar] [CrossRef] [Green Version]
  77. Bannantine, J.P.; Griffiths, R.S.; Viratyosin, W.; Brown, W.J.; Rockey, D.D. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell. Microbiol. 2000, 2, 35–47. [Google Scholar] [CrossRef] [Green Version]
  78. Rockey, D.D.; Scidmore, M.A.; Bannantine, J.P.; Brown, W.J. Proteins in the chlamydial inclusion membrane. Microbes Infect. 2002, 4, 333–340. [Google Scholar] [CrossRef]
  79. Lutter, E.I.; Martens, C.; Hackstadt, T. Evolution and conservation of predicted inclusion membrane proteins in chlamydiae. Comp. Funct. Genom. 2012, 2012, 362104. [Google Scholar] [CrossRef] [Green Version]
  80. Rockey, D.D.; Grosenbach, D.; Hruby, D.E.; Peacock, M.G.; Heinzen, R.A.; Hackstadt, T. Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion. Mol. Microbiol. 1997, 24, 217–228. [Google Scholar] [CrossRef]
  81. Rockey, D.D.; Heinzen, R.A.; Hackstadt, T. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol. Microbiol. 1995, 15, 617–626. [Google Scholar] [CrossRef]
  82. Scidmore, M.A.; Hackstadt, T. Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol. Microbiol. 2001, 39, 1638–1650. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Aeberhard, L.; Banhart, S.; Fischer, M.; Jehmlich, N.; Rose, L.; Koch, S.; Laue, M.; Renard, B.Y.; Schmidt, F.; Heuer, D. The Proteome of the Isolated Chlamydia trachomatis Containing Vacuole Reveals a Complex Trafficking Platform Enriched for Retromer Components. PLoS Pathog. 2015, 11, e1004883. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Mirrashidi, K.M.; Elwell, C.A.; Verschueren, E.; Johnson, J.R.; Frando, A.; Von Dollen, J.; Rosenberg, O.; Gulbahce, N.; Jang, G.; Johnson, T.; et al. Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection. Cell Host Microbe 2015, 18, 109–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Bastidas, R.J.; Elwell, C.A.; Engel, J.N.; Valdivia, R.H. Chlamydial intracellular survival strategies. Cold Spring Harb. Perspect. Med. 2013, 3, a010256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Elwell, C.; Mirrashidi, K.; Engel, J. Chlamydia cell biology and pathogenesis. Nat. Rev. Microbiol. 2016, 14, 385–400. [Google Scholar] [CrossRef]
  87. Mehlitz, A.; Banhart, S.; Maurer, A.P.; Kaushansky, A.; Gordus, A.G.; Zielecki, J.; Macbeath, G.; Meyer, T.F. Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J. Cell Biol. 2010, 190, 143–157. [Google Scholar] [CrossRef] [Green Version]
  88. Kintner, J.; Moore, C.G.; Whittimore, J.D.; Butler, M.; Hall, J.V. Inhibition of Wnt Signaling Pathways Impairs Chlamydia trachomatis Infection in Endometrial Epithelial Cells. Front. Cell. Infect. Microbiol. 2017, 7, 501. [Google Scholar] [CrossRef] [Green Version]
  89. Stephens, R.S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 2003, 11, 44–51. [Google Scholar] [CrossRef]
  90. Igietseme, J.U.; Omosun, Y.; Stuchlik, O.; Reed, M.S.; Partin, J.; He, Q.; Joseph, K.; Ellerson, D.; Bollweg, B.; George, Z.; et al. Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis. PLoS ONE 2015, 10, e0145198. [Google Scholar] [CrossRef]
  91. Krull, M.; Klucken, A.C.; Wuppermann, F.N.; Fuhrmann, O.; Magerl, C.; Seybold, J.; Hippenstiel, S.; Hegemann, J.H.; Jantos, C.A.; Suttorp, N. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J. Immunol. 1999, 162, 4834–4841. [Google Scholar]
  92. Kol, A.; Bourcier, T.; Lichtman, A.H.; Libby, P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Investig. 1999, 103, 571–577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Bulut, Y.; Faure, E.; Thomas, L.; Karahashi, H.; Michelsen, K.S.; Equils, O.; Morrison, S.G.; Morrison, R.P.; Arditi, M. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 2002, 168, 1435–1440. [Google Scholar] [CrossRef] [PubMed]
Pathogens 09 01034 g001 550
Figure 1. Modulation of extrusion by Chlamydia. CT228 and MrcA interact with MYPT1 and ITPR3, respectively, to regulate the phosphorylation state of MLC2. Active phosphorylated MLC2 correlates with extrusion whereas inactive unphosphorylated MLC2 correlates with lysis. ITPR3 along with STIM1 control Ca2+ concentrations to influence relative active levels of MLCK and MYPT1 to regulate extrusion.
Figure 1. Modulation of extrusion by Chlamydia. CT228 and MrcA interact with MYPT1 and ITPR3, respectively, to regulate the phosphorylation state of MLC2. Active phosphorylated MLC2 correlates with extrusion whereas inactive unphosphorylated MLC2 correlates with lysis. ITPR3 along with STIM1 control Ca2+ concentrations to influence relative active levels of MLCK and MYPT1 to regulate extrusion.
Pathogens 09 01034 g001
Pathogens 09 01034 g002 550
Figure 2. Host kinases manipulated by Chlamydia to promote survival. Schematic contains a summary of host kinases manipulated by Chlamydia to inhibit apoptosis. EB binding and entry activate PI3K and ERK1/2 to promote survival. TarP activates Erk1/2. Sequestration of PKC, 14-3-3β, PDPK1, and GSK3β work via different mechanisms to prevent apoptosis.
Figure 2. Host kinases manipulated by Chlamydia to promote survival. Schematic contains a summary of host kinases manipulated by Chlamydia to inhibit apoptosis. EB binding and entry activate PI3K and ERK1/2 to promote survival. TarP activates Erk1/2. Sequestration of PKC, 14-3-3β, PDPK1, and GSK3β work via different mechanisms to prevent apoptosis.
Pathogens 09 01034 g002
Table
Table 1. Host kinases and their roles in chlamydial infection.
Table 1. Host kinases and their roles in chlamydial infection.
Host KinaseImplicated Roles in Chlamydial InfectionReferences
Src, Abl, SykPhosphorylation T3SS effectors TarP and TepP. Important for entry, inclusion development and regulation of innate immune response[17,18,19,20,21,22]
FAKRecruited by TarP
Actin remodeling during entry		[23,24]
SFKs (Src, Fyn)Microdomain localization
Microtubule dependent trafficking of inclusion to MTOC
Intracellular development
Lipid acquisition 		[25,26,27]
MLCKMicrodomain localization with other elements of Myosin pathway
Regulation of extrusion		[28,29,30]
RTKs (PDGFR, FGFR, EGFR, EPHA2)Chlamydial entry and invasion
F-actin assembly around inclusion
Host cell survival		[18,31,32,33,34]
PI4KIIαGeneration of a pool of PI4P around inclusion
Important for infectious progeny and inclusion formation		[35]
PI3K/AKTInvasion
Apoptosis resistance
Chlamydial replication
Dampening of innate immune response
Sphingolipid acquisition
Reduction of tumor suppressor protein p53		[21,34,36,37,38,39,40,41]
PDPK1Apoptosis resistance[42]
GSK3βInteracts with Cpn1027
Recruitment by TepP		[21,43]
PKCResistance to apoptosis
Microdomain localization
Potential role in lipid acquisition 		[44,45,46,47]
MEK/ERK Lipid acquisition
Bacterial replication
Apoptosis resistance
cytokine IL-8, IL-10 induction
Chlamydia induced epithelial-to-mesenchymal transition
Proliferation of vasculature smooth muscle cells		[18,23,31,32,36,40,48,49,50,51,52,53,54,55,56,57,58]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sah, P.; Lutter, E.I. Hijacking and Use of Host Kinases by Chlamydiae. Pathogens 2020, 9, 1034. https://doi.org/10.3390/pathogens9121034

AMA Style

Sah P, Lutter EI. Hijacking and Use of Host Kinases by Chlamydiae. Pathogens. 2020; 9(12):1034. https://doi.org/10.3390/pathogens9121034

Chicago/Turabian Style

Sah, Prakash, and Erika I. Lutter. 2020. "Hijacking and Use of Host Kinases by Chlamydiae" Pathogens 9, no. 12: 1034. https://doi.org/10.3390/pathogens9121034

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop